Clear Lake Specialties

Webster, Texas 77598

0 studies enrolling now · 10 studies all time

What they study most

Benign Prostatic Hyperplasia, Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, Endocrine System Diseases, FSGS, Gastro-Intestinal Tolerance, Glomerulonephritis, Glomerulosclerosis, Focal Segmental, Gout, Kidney Diseases, Kidney Transplant

Studies at this site

• A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB — Recruiting now
• Optilume™ BPH Catheter System in Men With Symptomatic BPH — Running, not enrolling
• Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant — Completed
• Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout — Completed
• Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension — Completed
• Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN — Stopped early
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) — Completed
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — Stopped early
• Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula — Stopped early
• A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA) — Completed